China · Series B startup

Who invested in Magpie Pharmaceuticals

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$15Mraised across 1 round since 2019, from 1 source

Latest round
Series B, $15MFeb 2019
Investors
1
See who backed them

The rounds

  1. Feb 2019
    Series B$15M

    Reported by China Money Network

Everyone who backed them

Sangel CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Magpie Pharmaceuticals

Who invested in Magpie Pharmaceuticals?

Magpie Pharmaceuticals's investors include Sangel Capital.

How much has Magpie Pharmaceuticals raised?

Magpie Pharmaceuticals has raised $15M across 1 round since 2019.

When did Magpie Pharmaceuticals last raise?

Magpie Pharmaceuticals's most recent round was a Series B of $15M in Feb 2019.

What was Magpie Pharmaceuticals's biggest round?

Its most recent round, $15M in Feb 2019, is also its largest on record.

Who backed Magpie Pharmaceuticals first?

Magpie Pharmaceuticals's first round on record, in Feb 2019, was backed by Sangel Capital.

What stage is Magpie Pharmaceuticals at?

Magpie Pharmaceuticals's latest named round is a Series B, in Feb 2019.

Where is Magpie Pharmaceuticals based?

Magpie Pharmaceuticals is based in China.

Companies like Magpie Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.